Following up on our previous post on magic mushrooms, the Washington Post is reporting that NIMH researchers have reported success using ketamine (commonly used as an anesthetic) to treat patients with multi-drug resistant depression. Apparently the study is still in progress and currently enrolling participants. Taken with the research on psilocybin, it seems to be that taboos are weakening when it comes to research on compounds which are frequently used for recreational purposes.
Perhaps from over-usage of their own medicine, researchers who advocated for the use of LSD in psychology have appeared kooky, at best and the cause of compassion towards cancer patients is only hurt when everyone showing up to the medical marijuana rally is wearing tie-dye. All of this leads to a backlash by conservative elements against serious study. But ketamine has been around since the 60's, and I think that it was the abuse of the drug rather than it's clinical use which lead to more robust study culminating with the results obtained by NIMH.